What is the appropriate dose of amoxicillin‑clavulanate (Augmentin) for an 8‑year‑old boy with otitis media who previously failed amoxicillin therapy and weighs 20.37 kg?

High-Dose Amoxicillin-Clavulanate: 1,833 mg/day (90 mg/kg/day amoxicillin component)

For this 8-year-old boy weighing 20.37 kg with otitis media who failed amoxicillin, prescribe high-dose amoxicillin-clavulanate at 90 mg/kg/day of the amoxicillin component (1,833 mg amoxicillin/day) divided into 2 doses for 10 days.

Dosing Calculation

• Weight: 20.37 kg
• Amoxicillin component: 90 mg/kg/day = 1,833 mg/day
• Divided into 2 doses: 916.5 mg twice daily
• Duration: 10 days

Practical Formulation Options

Using the 14:1 ratio formulation (Augmentin ES-600 or equivalent):

• 600 mg amoxicillin/42.9 mg clavulanate per 5 mL
• Give 7.6 mL twice daily (provides 912 mg amoxicillin per dose)

Alternatively, using standard high-dose tablets:

• Use formulation providing 90 mg/kg amoxicillin with 6.4 mg/kg clavulanate daily

Rationale for High-Dose Amoxicillin-Clavulanate

The 2013 AAP guideline for acute otitis media 1 explicitly recommends high-dose amoxicillin-clavulanate (90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate) as first-line treatment after amoxicillin failure. This child has already failed standard amoxicillin therapy, which places him in the category requiring broader coverage.

The WHO Pocket Book 2 recommends amoxicillin 40 mg/kg twice daily for 5 days as initial therapy for otitis media, but this child has already failed that approach. The higher dose addresses:

1. Penicillin-resistant Streptococcus pneumoniae: High-dose amoxicillin achieves middle ear fluid concentrations sufficient to overcome resistance from altered penicillin-binding proteins 1

2. β-lactamase-producing organisms: The clavulanate component inhibits β-lactamases produced by Haemophilus influenzae (10-42% are β-lactamase positive) and Moraxella catarrhalis (nearly 100% produce β-lactamase) 1

3. Treatment failure risk factors: This child has recent antibiotic exposure (failed amoxicillin), which is a specific indication for amoxicillin-clavulanate rather than amoxicillin alone 3, 1

Evidence Supporting This Approach

The FDA-approved Augmentin ES-600 studies 4 demonstrated 98.4% bacteriologic eradication of S. pneumoniae (including 91% of penicillin-resistant strains with MICs of 2-4 mcg/mL) and 92.6% eradication of H. influenzae using 90/6.4 mg/kg/day dosing. Clinical success at 2-4 days post-therapy was 89.1% for S. pneumoniae and 87.0% for H. influenzae.

A 2001 study 5 of 521 children treated with high-dose amoxicillin-clavulanate (90/6.4 mg/kg/day) showed 96% overall pathogen eradication, including 91% of penicillin-resistant S. pneumoniae isolates. Clinical response (resolution or improvement) occurred in 89% of children.

Recent 2022 data 6 from over 1 million children showed that while treatment failure rates were low across all antibiotics (2.2% overall), amoxicillin-clavulanate had higher combined failure/recurrence rates (11.3%) than amoxicillin alone (1.7%). However, this child has already failed amoxicillin, making amoxicillin-clavulanate the appropriate next step per guidelines 1.

Why Not Other Options?

Cefdinir or other oral cephalosporins: While the AAP guideline 1 lists these as alternatives for penicillin allergy, they are not preferred after amoxicillin failure when the child can tolerate β-lactams. High-dose amoxicillin-clavulanate provides superior coverage against both resistant S. pneumoniae and β-lactamase producers.

Ceftriaxone (50 mg/kg IM/IV): Reserved for children who are vomiting, cannot tolerate oral medication, or remain significantly symptomatic after 24 hours of oral therapy 1. This child doesn't meet these criteria yet.

Standard-dose amoxicillin-clavulanate (45 mg/kg/day): Insufficient for treatment failure cases and areas with high penicillin-resistant S. pneumoniae prevalence 3, 1.

Common Pitfalls to Avoid

1. Underdosing: The most common error is prescribing standard-dose (45 mg/kg/day) rather than high-dose (90 mg/kg/day) amoxicillin-clavulanate. A 2013 study 7 found 89.1% of prescriptions were underdosed, though this only significantly affected outcomes in children <20 kg with bilateral disease.

2. Wrong clavulanate ratio: Ensure you're using a formulation with the 14:1 ratio (90 mg/kg amoxicillin with 6.4 mg/kg clavulanate), not older 4:1 or 7:1 ratios that provide excessive clavulanate and increase diarrhea risk 8.

3. Inadequate duration: Treat for 10 days, not 5-7 days, particularly after treatment failure 3, 1.

4. Ignoring diarrhea risk: Protocol-defined diarrhea occurs in 11-13% of children on high-dose formulations 4. Counsel parents about this expected side effect and distinguish it from treatment failure. A 2017 study 9 showed reduced-clavulanate formulations (80 mg/kg amoxicillin with 2.85 mg/kg clavulanate) reduced diaper dermatitis from 33% to 21% without compromising efficacy, though this isn't yet standard practice.

Reassessment Plan

Evaluate clinical response at 48-72 hours. If the child shows no improvement or worsens, consider:

• Tympanocentesis for culture if available and skilled provider present 1
• Ceftriaxone 50 mg/kg IM/IV daily for 3 days 1
• Infectious disease consultation if multidrug-resistant bacteria suspected 1